Treatment of CIN-lesions by enhancing immunitary action in the uterine cervix.
Phase of Trial: Phase IV
Latest Information Update: 18 Nov 2015
Price : $35 *
At a glance
- Drugs Imiquimod (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Therapeutic Use
- 14 Nov 2015 Planned number of patients changed from 180 to 210 as per European Clinical Trials Database record.
- 27 Sep 2014 New trial record